KZIA — Kazia Therapeutics Balance Sheet
0.000.00%
Last trade - 00:00- $0.03m
- $3.55m
- AU$2.32m
Annual balance sheet for Kazia Therapeutics, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.
2020 June 30th | R2021 June 30th | R2022 June 30th | 2023 June 30th | 2024 June 30th | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | 20-F |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 8.76 | 27.6 | 7.36 | 5.24 | 1.66 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 1.35 | 0.084 | 0.091 | 3.9 | 3.9 |
| Prepaid Expenses | |||||
| Total Current Assets | 10.7 | 29.4 | 9.45 | 10.8 | 6.14 |
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 23.1 | 57.1 | 35.9 | 28.1 | 21.6 |
| Accounts Payable | |||||
| Payable / Accrued | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 5.07 | 5.95 | 6.73 | 7.57 | 25.8 |
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 8.94 | 19.2 | 17.6 | 16 | 31.6 |
| Common Stock | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 14.1 | 37.9 | 18.3 | 12.1 | -10 |
| Total Liabilities & Shareholders' Equity | 23.1 | 57.1 | 35.9 | 28.1 | 21.6 |
| Total Common Shares Outstanding |